| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.07 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.07 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.08 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |